Israel startup OurCrowd, an equity Crowdfunding platform, has announced that it has closed its Series A funding round, raising a total of $5.5 million. The company says that during its first quarter of operation, companies using the platform raised an average of $500,000 and $12 million in total.
News Briefs
February 06, 2013
OurCrowd Raises $5.5M In Series A Funding
February 06, 2013
Can-Fite BioPharma Raises $7.2M In Secondary Offering
Israeli pharmaceutical company Can-Fite BioPharma Ltd. has announced that it has raised NIS 26.5 million ($7.2 million) in its secondary offering on the Tel Aviv stock exchange. The company says that it will direct the funds towards a phase II/III clinical trial of its psoriasis treatment.
February 06, 2013
Upstream Commerce Raises $3M
Israeli startup company Upstream Commerce, which develops automated online solutions for pricing for retailers using a Software as a Service (SaaS) platform, has announced that it has raised $3 million in a financing round. The round as led by YL Ventures and Bright Capital, which were joined by other private investors.
February 06, 2013
Gamida Cell Reports Success On Leukemia And Lymphoma Treatment
Israeli stem cell therapy company Gamida Cell Ltd. has announced success in the Phase III clinical trial of its treatment for leukemia and lymphoma StemEx. The results show a mortality rate which is 35.5 percent lower for people treated with StemEx, as opposed to people who were not.
February 06, 2013
Hadassah’s Dr. Amal Bishara Receives “Outstanding Woman Scientist Award”
Dr. Amal Bishara, initiator and head of the Hadassah Medical Center‘s Arab Bone Marrow Registry Outreach Project, has been named “an outstanding woman scientist in the Middle East and North Africa” by the United States Department of State. One of 13 women to receive this honor, Dr. Bishara was presented with the certificate in a ceremony at the residence of US Ambassador to Israel Daniel Shapiro.
February 05, 2013
BioCancell Reports Positive Results On Pancreatic Cancer Treatment
Israeli company BioCancell Therapeutics Ltd., has announced positive results in a Phase IIb clinical trial of its BC-819 treatment for pancreatic cancer. The study showed that the drug is safe for all patients and that increasing the dosage of the drug does not cause deterioration in the patients’ condition.
February 05, 2013
Cloud Application Platform Ravello Raises $26M
Israeli-founded company Ravello Systems, which is “the industry’s first ‘cloud application platform,'” has announced that it has raised $26 million in a financing round. The round was led by Sequoia Capital, with participation from Norwest Venture Partners and Bessemer Venture Partners.
February 05, 2013
First Pateinet Begins Treatment With BrainStorm’s ALS Therapy
BrainStorm Cell Therapeutics, a leading developer of adult stem cell technologies for neurodegenerative diseases, has announced that the first patient began treatment in the Company’s Phase IIa dose-escalating clinical trial for ALS. The trial, which will evaluate the safety and preliminary efficacy of BrainStorm’s NurOwn stem cell therapy candidate, is being conducted at the Hadassah Medical Center in Jerusalem.
February 05, 2013
Technion and Alpha Szenszor Announce Joint Venture in Lung Cancer Diagnostics
The Technion – Israel Institute of Technology and Alpha Szenszor Inc., a provider of carbon nanotube based sensors, have announced a joint venture for the commercialization of advanced lung cancer diagnostics based on Volatile Organic Compound (VOC) detection from human breath. The two organizations plan to merge expertise to commercialize an economically viable, non-invasive, digital tool for the early diagnosis of lung cancer.
February 05, 2013
Bloomberg Ranks Israel First In R&D On Global Innovation Index
International news agency Bloomberg has published its Global Innovation Index. Israel is ranked 1st in the Research and Development category and 32nd overall. Israel has also achieved a high ranking in the high-tech density and tertiary efficiency, ranking 7th in both.
February 05, 2013
Monsanto buys Rosetta Green for $35m
Israeli seed-engineering company Rosetta Green has been acquired by international seed giant Monsanto. The latter has agreed to pay $35 million for the former, practically doubling the Israeli company’s market value.
February 04, 2013
Stratasys’ Wins Design World’s Leadership in Engineering Program
Israeli-American company Stratasys, Ltd., a manufacturer of 3D printers and production systems for prototyping and manufacturing, has announced its Objet line of 3D printers has been named a winner in Design World’s sixth annual Leadership in Engineering program. The company’s technology won the Digital Manufacturing category.
February 04, 2013
ClickSoftware Reports Record Revenues of $100 Million for 2012
Israeli-American company ClickSoftware Technologies Ltd., a provider of automated workforce management and optimization solutions for the service industry, has announced its financial results for 2012. The company has reported annual revenue of $100 million, a 15 percent growth from 2011 and an all-time record for the company.
February 04, 2013
NASA Administrator Launches New Space Center In Sakhnin
Arab-Israeli town Sakhnin has a new feather in its cap: the Moona science, environment and space center. The center was inaugurated in a ceremony attended by NASA administrator Charles Bolden. The center will offer residents of the area to collaborate with one another in order to develop various solutions for regional issues.
February 04, 2013
Gigya Says It Reached 1.5B Monthly Users In 2012
Israeli company Gigya, which provides websites with a social infrastructure that creates social experiences for users and provides customer insights for businesses, has announced that it has reached 1.5 billion users a month in 2012, up 500 million from 2011. Gigya says it has expanded its clientele to include power players such as Wal-Mart and DirectTV, reaching a total of 650 clients.
